Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: The role of glutathione

Pediatrics, National Jewish Health, Denver, Colorado, USA.
Toxicology and Applied Pharmacology (Impact Factor: 3.71). 08/2011; 258(1):1-9. DOI: 10.1016/j.taap.2011.08.004
Source: PubMed


We hypothesized that flavonoid-induced glutathione (GSH) efflux through multi-drug resistance proteins (MRPs) and subsequent intracellular GSH depletion is a viable mechanism to sensitize cancer cells to chemotherapies. This concept was demonstrated using chrysin (5-25 μM) induced GSH efflux in human non-small cell lung cancer lines exposed to the chemotherapeutic agent, doxorubicin (DOX). Treatment with chrysin resulted in significant and sustained intracellular GSH depletion and the GSH enzyme network in the four cancer cell types was predictive of the severity of chrysin induced intracellular GSH depletion. Gene expression data indicated a positive correlation between basal MRP1, MRP3 and MRP5 expression and total GSH efflux before and after chrysin exposure. Co-treating the cells for 72 h with chrysin (5-30 μM) and DOX (0.025-3.0 μM) significantly enhanced the sensitivity of the cells to DOX as compared to 72-hour DOX alone treatment in all four cell lines. The maximum decrease in the IC(50) values of cells treated with DOX alone compared to co-treatment with chrysin and DOX was 43% in A549 cells, 47% in H157 and H1975 cells and 78% in H460 cells. Chrysin worked synergistically with DOX to induce cancer cell death. This approach could allow for use of lower concentrations and/or sensitize cancer cells to drugs that are typically resistant to therapy.

Download full-text


Available from: Remy Kachadourian
  • Source
    • "Please cite this article as: Rocha, G.d.G., et al., 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and.... Eur J Pharmacol (2014), Considering the involvement of GSTs in the transport of GSHconjugated drugs (Brechbuhl et al., 2012), we analyzed the effect of 3ATA on GST activity. Cells were treated with 3ATA for 24 h with 12.5, 25 or 50 mg/ml of 3ATA, and the resulting GST activity was measured using a colorimetric assay kit (BioVision) based upon the GST-catalyzed reaction between GSH and the GST substrate, CDNB (1-chloro-2,4-dinitrobenzene) as described in Section 2. The results shown in Fig. 5B demonstrate that cells exposed to 3ATA for 24 h exhibited significant dose-dependent decreases in GST activity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mechanisms involved in sensitization of cancer cells by 3ATA. (1) By inhibiting the MRP1 activity, 3ATA increases the intracellular pool of drug allowing it to reach effective cytotoxic/lethal concentration. (2) This effect is also due to the ability of 3ATA in inhibiting GST activity and therefore, decreasing the amount of conjugated drug to be transported. (3) 3ATA decreases the intracellular pool of GSH contributing to limit the availability of cellular GSH needed for metabolizing and transporting some alkylating agents out of the cell. (4) By affecting/altering the GSH pool, 3ATA also decreases the antioxidant capacity of the cell, favors ROS accumulation. The overall result of these mechanisms is increased accumulation of drugs and cell death. Figure optionsDownload full-size imageDownload high-quality image (232 K)Download as PowerPoint slide
    Preview · Article · Oct 2014 · European Journal of Pharmacology
  • [Show abstract] [Hide abstract]
    ABSTRACT: The investigation of chemotherapeutic agents for the treatment of cancer since the early 1940s has resulted in the discovery of over 50 drugs till date. However, most of these drugs result in severe side effects causing physical and mental trauma to patients. In order to eliminate the side effects, search for better and safer drugs has been ongoing for several decades, which has resulted in the discovery of anti�cancer properties of many phytochemicals. Polyphenols represent a unique class of phytochemicals that possess excellent anti�oxidant, anti�inflammatory properties and also modulate cell signalling pathways leading to anti�cancer effects. However, the use of these compounds as anti�cancer agents is not as effective and hence combinations of chemotherapeutic drugs with these molecules have been attempted. Promising results in in vitro and in vivo experiments while using combinations of polyphenols and chemotherapeutic agents open up new avenues for the discovery of the ideal drug combinations for cancer therapy. This review highlights the efficacy of the combination of phytochemicals with synthetic anti�neoplastic drugs over the conventional combinations of anti�neoplastic drugs and the possible interventions in the clinical settings. The review also discusses the inclusion of polyphenols in emerging therapeutic modalities like nanotechnology and photodynamic therapy.
    No preview · Article · Jun 2012 · Anti-cancer agents in medicinal chemistry
  • [Show abstract] [Hide abstract]
    ABSTRACT: Zebularine (Zeb) as a DNA methyltrasferase (DNMT) inhibitor has various cellular effects such as cell growth inhibition and apoptosis. In the present study, we evaluated the effects of Zeb on the growth and death of HeLa cervical cancer cells. Zeb inhibited the growth of HeLa cells with an IC50 of approximately 130 μM at 72 h in a dose-dependent manner. DNA flow cytometric analysis indicated that Zeb induced an S phase arrest of the cell cycle, which was accompanied by the increased levels of cdk2 and cyclin A proteins. This agent also induced apoptosis, which was accompanied by the loss of mitochondrial membrane potential (Ψm), PARP-1 cleavage and the activation of caspase-3, -8 and -9. All of the tested caspase inhibitors significantly rescued some cells from Zeb-induced HeLa cell death. In relation to reactive oxygen species (ROS) and glutathione (GSH) levels, O 2•− level was significantly increased in 100 μM Zeb-treated HeLa cells and caspase inhibitors reduced O 2•− level in these cells. Zeb induced GSH depletion in HeLa cells, which was attenuated by caspase inhibitors. In conclusion, this is the first report that Zeb inhibited the growth of HeLa cells via cell cycle arrest and apoptosis.
    No preview · Article · Jun 2012 · Molecular Biology Reports
Show more

Similar Publications